Cell Point (India) (NSE:CELLPOINT) Total Liabilities: ₹948 Mil (As of Mar. 2026)


NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
73 GF Score
Price ₹15.80
GF Value ₹34.77
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cell Point (India) Total Liabilities?

Cell Point (India) NSE:CELLPOINT +5.33% 73 Total Liabilities is ₹948 Mil as of Mar. 2026. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 73/100 and a GF Value™ of ₹34.77 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Cell Point (India)'s Total Liabilities for the quarter that ended in Mar. 2026 was ₹948 Mil.

Cell Point (India)'s quarterly Total Liabilities increased from Mar. 2025 (₹639.04 Mil) to Sep. 2025 (₹881.64 Mil) and increased from Sep. 2025 (₹881.64 Mil) to Mar. 2026 (₹947.88 Mil).

Cell Point (India)'s annual Total Liabilities increased from Mar. 2024 (₹620.00 Mil) to Mar. 2025 (₹639.04 Mil) and increased from Mar. 2025 (₹639.04 Mil) to Mar. 2026 (₹947.88 Mil).

Cell Point (India) Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) Total Liabilities Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial 693.45 744.48 620.00 639.04 947.88

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 620.00 0.00 639.04 881.64 947.88
NSE:CELLPOINT
73GF Score
Cell Point (India) Ltd NSE:CELLPOINT
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cell Point (India)'s Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=629.831+(311.495+6.55
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=948

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=1691.05-743.174
=948

Cell Point (India)'s Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=629.831+(311.495+6.55
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=948

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1691.05-743.174
=948

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹948 Mil mean?
Cell Point (India) (NSE:CELLPOINT) has a Total Liabilities of ₹948 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cell Point (India) and its competitors.
Is Cell Point (India)'s Total Liabilities too high?
Cell Point (India)'s current Total Liabilities is ₹948 Mil. Overall, Cell Point (India) has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Total Liabilities compare to CASY and WSM?
Cell Point (India)'s Total Liabilities of ₹948 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Retail - Cyclical company?
A good Total Liabilities depends on the Retail - Cyclical industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cell Point (India) and its competitors. Cell Point (India)'s current Total Liabilities is ₹948 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.77, compared to a current price of ₹15.80 — trading 54.6% below its estimated fair value. The current Total Liabilities is ₹948 Mil. Cell Point (India)'s overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Total Liabilities is ₹948 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹15.80 is trading 54.6% below its estimated GF Value™ of ₹34.77. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • Total Liabilities: ₹948 Mil
  • GF Value™: ₹34.77 vs. price of ₹15.80 (54.6% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
73GF Score

Get the complete analysis for NSE:CELLPOINT

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.80
Price
₹34.77
GF Value